30-day vs. 90-day total joint replacement episodes — which best captures readmissions? 5 notes

A new study published in the Journal of Arthroplasty examines whether 30-day or 90-day readmission reporting for primary total joint replacement is sufficient.

Advertisement

 

The study included 2,586 patients who underwent total hip or knee replacements from Jan. 1, 2013 to Dec. 31, 2015. EHR records were reviewed for all patients and researchers found:

1. There wasn’t a difference in proportion of surgery-related readmissions over the 30-day and 90-day timeframe. Around 71 percent of the 30-day readmissions were surgery-related, compared to 60 percent of the 90-day readmissions.

2. More of the 30-day readmissions were reported as surgery-related complications when compared with the amount of readmissions from day 31 to day 90; 71 percent of the complications within the first 30 days were related to surgery, compared to 47 percent of the remaining 60 days in a 90-day episode.

3. In total, there were 104 patients readmitted within the first year of discharge and 52 percent of those readmissions occurred within the first 30 days after surgery; by 90 days after surgery, 79 percent of those readmissions had occurred.

4. Researchers found similar conclusions when examining the 30-and 90-day post-discharge definitions. Around 53 percent of readmissions were reported within 30 days of discharge and 81 percent within 90 days of discharge.

5. Researchers concluded, “A 90-day timeframe is superior in capturing surgery-related readmissions after total joint arthroplasty. Important total hip and knee arthroplasty adverse events may be missed using a 30-day timeframe.”

More articles on orthopedics:
OrthoAtlanta adds Dr. Christopher Burket to staff—3 insights
Total joints in ASCs are a win-win-win—Dr. Michael Chmell outlines key trends for the future
Outlook for total joint replacements in the ASC: Key concepts from Dr. Thomas K. Miller

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedics / TJR

Advertisement

Comments are closed.